C. Wiblin - Concepedia

Author

C. Wiblin

Salisbury University

Also Known As

C N Wiblin, C Wiblin, C. N. WIBLIN, C. N. Wiblin, C. Wiblin, C.N. Wiblin, Christopher N. Wiblin

Publications

435

Citations

H-Index

Concepts

All Affiliations

Salisbury University Defence Science and Technology Laboratory University of Birmingham The Honourable Society of Lincoln's Inn Birmingham City University

About

C. Wiblin is an author at Salisbury University specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	276
2	Biochemistry	4	4	171
3	Natural Sciences	3	3	144
4	Public Health	1	1	20
5	Allergy	1	1	49

C. Wiblin

Publications

414

Citations

H-Index

Page 1

	Year	Citations
Covalent linkage of carboxypeptidase G2 to soluble dextrans—I Roger G. Melton, C. Wiblin, R. L. Foster, Biochemical Pharmacology Bioorganic ChemistryBiochemistryNatural SciencesGlycobiologyCovalent Linkage	1987	63
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis. G. R. B. Skinner, C B J Woodman, Christopher Hartley, Sexually Transmitted Infections Vaccine Ac Nfu1ImmunologyImmunotherapySubunit Antigenoid VaccineVaccine Target	1982	49
Enhanced plasma persistence of therapeutic enzymes by coupling to soluble dextran R.F. Sherwood, J. Kevin Baird, Tony Atkinson, Biochemical Journal Pharmaceutical ScienceCellular EnzymologyBiochemistryMedicineNatural Sciences	1977	45
The transformation of BHK 21 hamster cells by simian virus 40 C. Wiblin, Ian Macpherson International Journal of Cancer Viral ReplicationImmunologyViral PathogenesisPathologyImmunodominance	1972	38
Covalent linkage of carboxypeptidase G2 to soluble dextrans—II Roger G. Melton, C. Wiblin, A. Baskerville, Biochemical Pharmacology Bioorganic ChemistryBiochemistryNatural SciencesGlycobiologyCovalent Linkage	1987	36
Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis G. R. B. Skinner, Colin G. Fink, J. Melling, Medical Microbiology and Immunology VaccinationVaccine SafetyHerpes GenitalisVaccine DevelopmentOpen Study	1992	30
The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animals J. E. Benbough, C. Wiblin, T.N.A. Rafter, Biochemical Pharmacology Animal PhysiologyBiochemistryMedicineBioanalysisPhysiology	1979	27
Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis. G. R. B. Skinner, Ciarán Woodman, Christopher Hartley, PubMed Vaccine Ac Nfu1ImmunologyType 1Vaccine TargetVaccine Surveillance	1982	27
Pathogenesis and immune response of vaccinated and unvaccinated rhesus monkeys to tick-borne encephalitis virus Peter Hambleton, John Stephenson, A. Baskerville, Infection and Immunity VaccinationVeterinary VaccineImmune Enhancement PhenomenonVaccine DevelopmentTick-borne Encephalitis Virus	1983	22
Complement‐Independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus C. Baboonian, K. Blake, J. C. Booth, Journal of Medical Virology	1989	22

Page 1